Interferon Therapy (HCV)

Long-Term Maintenance Interferon Therapy Has Role in Hepatitis C Treatment

Published in Hepatitis Weekly, November 15th, 1999

by Salynn Boyles, Senior Editor -- Long-term maintenance interferon therapy may be a valuable strategy in chronic hepatitis C virus patients who remain viremic.

At least half of patients with chronic hepatitis C virus (HCV) fail to respond to interferon or interferon/ribavirin therapy. Histological improvement is observed in some nonresponders.

In this randomized, controlled trial, researcher M.L. Shiffman and colleagues looked into whether maintenance interferon therapy could prevent histological progression in this subset of nonresponders ("A Randomized, Controlled Trial of Maintenance Interferon Therapy for Patients with Chronic Hepatitis C Virus...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (1999-11-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry